Multisystem vascular dysplasia: Osler-Weber-Rendu disease: unraveling the cause of the bleeding

Authors

  • Neftalí Alexander Granados Flores Instituto Salvadoreño del Seguro Social, San Salvador
  • José Alfonso Rumoroso García Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), México.

DOI:

https://doi.org/10.53903/01212095.229

Keywords:

Telangiectasia hemorrágica hereditaria, Displasia vascular multisistémica, Malformaciones arteriovenosas.

Abstract

Osler-Weber-Rendu disease (OWR), also known as multisystem vascular dysplasia or hereditary hemorrhagic telangiectasia, is a rare autosomal dominant disorder, characterized by the development of vascular dysplasias (VD) such as telangiectasias and arteriovenous malformations of mucocutaneous or visceral location, which show a tendency to bleeding, and can affect any organ or system, with epistaxis being the most frequent initial clinical presentation. Although the definitive diagnosis is based on genetic studies, due to their low availability and high cost, they have led to the use of imaging methods to identify findings that guide clinical suspicion. Three cases are presented with a diagnosis of OWR and imaging findings of hepatic, gastrointestinal and pulmonary DV levels.

Downloads

Download data is not yet available.

References

Lidia Duque E.; Nguyen Castro G.; José Larquin C.; Enfermedad de Rendu Osler Weber: presentación de un caso. Rev. Arch Med Camagüey Vol20(6)2016

K.E.C. Wirsching, T.S. Kühnel. Update on clinical strategies in hereditary hemorrhagic telangiectasia from an ENT point of view. Clin Exp Otorhinolaryngol, 10 (2017), pp. 153-157

T.L. Orizaga-y-Quiroga, A. Villarreal-Martínez, G. Jaramillo-Moreno, J. Ocampo-Candiani. Síndrome de Osler-Weber-Rendu y su relación con la dermatología. Vol. 110. Núm. 7. páginas 526-532 (septiembre 2019). DOI: 10.1016/j.ad.2018.11.007

Freyli Bustamante, Oscar T. Picón, Andrea Tenreiro, Ekaterina Bustamante. Síndrome de Rendu-Osler-Weber: presentación de un caso clínico. Avances en Biomedicina Publicación Oficial del Instituto de Inmunología Clínica Mérida-Venezuela Volumen 5(2), agosto 2016, p 104-10.

Jan Lerut, MD, PhD, et al and the European Liver Transplant Association. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg. 2016; 244:854-62

Sandoval DK, García E, Ramírez S, Torres KJ, Velandia MC, Villamizar JF, et al. Síndrome de Rendu Osler Weber en una adolescente en Colombia. Reporte de un caso de autopsia. Biosalud. 2018;17(1):83-9.

Marcos Cherem-Kibrit, Pablo G. da Silva, Francisco de la Vega G., Rubén Gutiérrez. Síndrome Osler-Weber-Rendu. Manejo endoscópico de un sangrado inusual. Endoscopia. 2021;32(2).

Kühnel T, Wirsching K, Wohlgemuth W, Chavan A, Evert K, Vielsmeier V. Hereditary hemorrhagic telangiectasia. Otolaryngol Clin North Am. 2018;51(1):237-54.

Bernardes C, Santos S, Loureiro R, Borges V, Ramos G. Bevacizumab for refractory gastrointestinal bleeding in Rendu-Osler-Weber disease. GE Port J Gastroenterol. 2018;25(2):91-5.

Ferri F, Ferri H. Osler-Weber-Rendu Syndrome. En: Ferri F, Ferri H. 2018 Ferri’s Clinical Advisor. Elsevier; 2018.

Published

2023-06-30

How to Cite

(1)
Granados Flores, N. A.; Rumoroso García, J. A. Multisystem Vascular Dysplasia: Osler-Weber-Rendu Disease: Unraveling the Cause of the Bleeding. Rev. colomb. radiol. 2023, 34, 5960-5965.

Issue

Section

Case reports
Article metrics
Abstract views81817
Galley views616
PDF Views616
HTML views0
Other views0